What is the ticker symbol for Cyclo Therapeutics?

Cyclo Therapeutics trades under the ticker CYTH on NASDAQ.

What sector does Cyclo Therapeutics operate in?

Cyclo Therapeutics is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

How can PortView help analyze CYTH in a portfolio?

PortView shows CYTH's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Cyclo Therapeutics (CYTH) Stock Analysis

NASDAQHealthcareDrug Manufacturers - Specialty & Generic

$0.72+0.00%

1-year price historyRange $0.57 – $1.53

52-week range$0.72

$0.55$1.62

What Cyclo Therapeutics does

Cyclo Therapeutics, Inc. operates as a clinical-stage biotechnology enterprise focused on developing treatments derived from cyclodextrins for various health conditions. Its flagship therapeutic candidate, Trappsol Cyclo, holds orphan drug status and is presently in Phase III clinical trials targeting Niemann-Pick Type C disease. The company is also investigating Trappsol Cyclo's efficacy in addressing Alzheimer's disease. Beyond its drug development pipeline, the firm engages in the sale of cyclodextrins and related commodities to sectors such as pharmaceuticals and nutrition, primarily for their application in diagnostics and specialized drug formulations. Originally established in 1990 as CTD Holdings, Inc., the company adopted its current name, Cyclo Therapeutics, Inc., in September 2019 and maintains its headquarters in Gainesville, Florida.

Key metrics

Market cap

$23.59M

P/E (TTM)

-0.80

EPS (TTM)

$-0.90

Beta

-0.57

Dividend yield

0.00%

Revenue / share

$0.07

50-day avg

$0.80

200-day avg

$0.83

52-week high

$1.62

52-week low

$0.55

CEO

N. Scott Fine

ETFs linked to CYTH

Broad-market and Healthcare sector ETFs an investor holding Cyclo Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CYTH fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CYTH in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Cyclo Therapeutics?: Cyclo Therapeutics trades under the ticker CYTH on NASDAQ.
Which exchange is CYTH listed on?: CYTH is listed on NASDAQ.
What sector does Cyclo Therapeutics operate in?: Cyclo Therapeutics is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
How can PortView help analyze CYTH in a portfolio?: PortView shows CYTH's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.